Hoth Therapeutics, Inc. — Director's Dealing 2024

Jan 8, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Hoth Therapeutics, Inc. (HOTH)
CIK: 0001711786
Period of Report: 2024-01-05

Reporting Person: Linsley Wayne (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-01-05	Options	$1.36	A	25000	Acquired	2034-01-05	Common Stock (25000)	Direct

Footnotes

F1: The options were issued pursuant to the Issuer's 2022 Equity Incentive Plan and vested in full upon grant.